InstellingenIk ga akkoord



10th Call IMI published

The JTI Innovative Medicines Initiative (IMI) has published the 10th Call for proposals. The closing date is January 28, 2014. The IMI 10th Call 2013 for proposals includes a topic covering the following key research priority: Infectious diseases (correlated to the area of interest: Disease Drug Efficacy). The 10th Call topic is: Immunological Assay Standardisation and Development for use in Assessments of Correlates Of Protection for Influenza Vaccines. Applicant Consortia are invited to submit expressions of interest to this topic. The expressions of interest should address all aspects of the topic.

The Innovative Medicines Initiative (IMI) is Europe's largest public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in Europe that will boost innovation in healthcare. Acting as a neutral third party in creating innovative partnerships, IMI aims to build a more collaborative ecosystem for pharmaceutical research and development (R&D). IMI will provide socio-economic benefits to European citizens, increase Europe's competitiveness globally and establish Europe as the most attractive place for pharmaceutical R&D.

Terug naar overzicht